Differential Efficacy of B-Ultrasound Combined with Molybdenum Target Detection Mode for Breast Cancer Staging and Correlation of Blood Flow Parameters with IGF-1 and IGF-2 Expression Level and Prognosis

<table class="table-group" id="tab5"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Group</td><td class="align_center">IGF-1 (<i>μ</i>g/L)</td><td class="align_center">IGF-2 (<i>μ</i>g/L)</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">Benign group (<i>n</i> = 58)</td><td class="align_center">27.37 ± 4.48</td><td class="align_center">28.68 ± 4.72</td></tr><tr><td class="align_left">Breast cancer stages I-II group (<i>n</i> = 54)</td><td class="align_center">37.93 ± 5.82</td><td class="align_center">48.36 ± 5.42</td></tr><tr><td class="align_left">Breast cancer stages III-IV group (<i>n</i> = 42)</td><td class="align_center">68.26 ± 6.15</td><td class="align_center">70.61 ± 6.47</td></tr><tr><td class="align_left"><i>F</i></td><td class="align_center">−10.803</td><td class="align_center">−20.529</td></tr><tr><td class="align_left"><i>P</i></td><td class="align_center">&lt;0.001</td><td class="align_center">&lt;0.001</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Comparison of IGF-1 and IGF-2 expression in each group.</div>

Contrast Media & Molecular Imaging

tab5

Table 5

Table 5: Differential Efficacy of B-Ultrasound Combined with Molybdenum Target Detection Mode for Breast Cancer Staging and Correlation of Blood Flow Parameters with IGF-1 and IGF-2 Expression Level and Prognosis 

Table 5 | Differential Efficacy of B-Ultrasound Combined with Molybdenum Target Detection Mode for Breast Cancer Staging and Correlation of Blood Flow Parameters with IGF-1 and IGF-2 Expression Level and Prognosis 